-+ 0.00%
-+ 0.00%
-+ 0.00%

60 DEGREES PHARMACEUTICALS SELECTS ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI AS CENTRAL CLINICAL TRIAL SITE FOR PHASE II STUDY TO EVALUATE TAFENOQUINE FOR CHRONIC BABESIOSIS

Reuters·08/19/2025 12:54:00

Please log in to view news